Migraine with aura and risk of cardiovascular and all cause mortality in men and women: prospective cohort study

To access publisher full text version of this article. Please click on the hyperlink in Additional Links field OBJECTIVE: To estimate whether migraine in mid-life is associated with mortality from cardiovascular disease, other causes, and all causes. DESIGN: Population based cohort study. SETTING: R...

Full description

Bibliographic Details
Published in:BMJ
Main Authors: Gudmundsson, Larus S, Scher, Ann I, Aspelund, Thor, Eliasson, Jon H, Johannsson, Magnus, Thorgeirsson, Gudmundur, Launer, Lenore, Gudnason, Vilmundur
Other Authors: Department of Pharmacology and Toxicology, University of Iceland, Hagi Hofsvallagata 53, IS-107 Reykjavik, Iceland. lsg@hi.is
Format: Article in Journal/Newspaper
Language:English
Published: British Medical Association 2010
Subjects:
Online Access:http://hdl.handle.net/2336/111153
https://doi.org/10.1136/bmj.c3966
id ftlandspitaliuni:oai:www.hirsla.lsh.is:2336/111153
record_format openpolar
spelling ftlandspitaliuni:oai:www.hirsla.lsh.is:2336/111153 2023-05-15T16:49:08+02:00 Migraine with aura and risk of cardiovascular and all cause mortality in men and women: prospective cohort study Gudmundsson, Larus S Scher, Ann I Aspelund, Thor Eliasson, Jon H Johannsson, Magnus Thorgeirsson, Gudmundur Launer, Lenore Gudnason, Vilmundur Department of Pharmacology and Toxicology, University of Iceland, Hagi Hofsvallagata 53, IS-107 Reykjavik, Iceland. lsg@hi.is 2010-08-14 http://hdl.handle.net/2336/111153 https://doi.org/10.1136/bmj.c3966 en eng British Medical Association http://dx.doi.org/10.1136/bmj.c3966 BMJ. 2010, 341(7771):493 1468-5833 20736269 doi:10.1136/bmj.c3966 http://hdl.handle.net/2336/111153 BMJ (Clinical research ed.) Migraine with Aura Iceland Cardiovascular Diseases Article 2010 ftlandspitaliuni https://doi.org/10.1136/bmj.c3966 2022-05-29T08:21:35Z To access publisher full text version of this article. Please click on the hyperlink in Additional Links field OBJECTIVE: To estimate whether migraine in mid-life is associated with mortality from cardiovascular disease, other causes, and all causes. DESIGN: Population based cohort study. SETTING: Reykjavik, Iceland. PARTICIPANTS: 18,725 men and women, born 1907-35 and living in Reykjavik and adjacent communities. MAIN OUTCOME MEASURES: Mortality from cardiovascular disease, non-cardiovascular disease, and all causes. Questionnaires and clinical measures were obtained in mid-life (mean age 53, range 33-81) in the Reykjavik Study (1967-91). Headache was classified as migraine without aura, migraine with aura, or non-migraine headache. Median follow-up was 25.9 years (0.1-40.2 years), with 470,990 person years and 10,358 deaths: 4323 from cardiovascular disease and 6035 from other causes. We used Cox regression to estimate risk of death in those with migraine compared with others, after adjusting for baseline risk factors. RESULTS: People with migraine with aura were at increased risk of all cause mortality (adjusted (for sex and multivariables) hazard ratio 1.21, 95% confidence interval 1.12 to 1.30) and mortality from cardiovascular disease (1.27, 1.13 to 1.43) compared with people with no headache, while those with migraine without aura and non-migraine headache were not. Further examination of mortality from cardiovascular disease shows that people with migraine with aura were at increased risk of mortality from coronary heart disease (1.28, 1.11 to 1.49) and stroke (1.40, 1.10 to 1.78). Women with migraine with aura were also at increased risk of mortality from non-cardiovascular disease (1.19, 1.06 to 1.35). CONCLUSIONS: Migraine with aura is an independent risk factor for cardiovascular and all cause mortality in men and women. The risk of mortality from coronary heart disease and stroke mortality is modestly increased in people with migraine, particularly those with aura. Article in Journal/Newspaper Iceland Hirsla - Landspítali University Hospital research archive BMJ 341 aug24 1 c3966 c3966
institution Open Polar
collection Hirsla - Landspítali University Hospital research archive
op_collection_id ftlandspitaliuni
language English
topic Migraine with Aura
Iceland
Cardiovascular Diseases
spellingShingle Migraine with Aura
Iceland
Cardiovascular Diseases
Gudmundsson, Larus S
Scher, Ann I
Aspelund, Thor
Eliasson, Jon H
Johannsson, Magnus
Thorgeirsson, Gudmundur
Launer, Lenore
Gudnason, Vilmundur
Migraine with aura and risk of cardiovascular and all cause mortality in men and women: prospective cohort study
topic_facet Migraine with Aura
Iceland
Cardiovascular Diseases
description To access publisher full text version of this article. Please click on the hyperlink in Additional Links field OBJECTIVE: To estimate whether migraine in mid-life is associated with mortality from cardiovascular disease, other causes, and all causes. DESIGN: Population based cohort study. SETTING: Reykjavik, Iceland. PARTICIPANTS: 18,725 men and women, born 1907-35 and living in Reykjavik and adjacent communities. MAIN OUTCOME MEASURES: Mortality from cardiovascular disease, non-cardiovascular disease, and all causes. Questionnaires and clinical measures were obtained in mid-life (mean age 53, range 33-81) in the Reykjavik Study (1967-91). Headache was classified as migraine without aura, migraine with aura, or non-migraine headache. Median follow-up was 25.9 years (0.1-40.2 years), with 470,990 person years and 10,358 deaths: 4323 from cardiovascular disease and 6035 from other causes. We used Cox regression to estimate risk of death in those with migraine compared with others, after adjusting for baseline risk factors. RESULTS: People with migraine with aura were at increased risk of all cause mortality (adjusted (for sex and multivariables) hazard ratio 1.21, 95% confidence interval 1.12 to 1.30) and mortality from cardiovascular disease (1.27, 1.13 to 1.43) compared with people with no headache, while those with migraine without aura and non-migraine headache were not. Further examination of mortality from cardiovascular disease shows that people with migraine with aura were at increased risk of mortality from coronary heart disease (1.28, 1.11 to 1.49) and stroke (1.40, 1.10 to 1.78). Women with migraine with aura were also at increased risk of mortality from non-cardiovascular disease (1.19, 1.06 to 1.35). CONCLUSIONS: Migraine with aura is an independent risk factor for cardiovascular and all cause mortality in men and women. The risk of mortality from coronary heart disease and stroke mortality is modestly increased in people with migraine, particularly those with aura.
author2 Department of Pharmacology and Toxicology, University of Iceland, Hagi Hofsvallagata 53, IS-107 Reykjavik, Iceland. lsg@hi.is
format Article in Journal/Newspaper
author Gudmundsson, Larus S
Scher, Ann I
Aspelund, Thor
Eliasson, Jon H
Johannsson, Magnus
Thorgeirsson, Gudmundur
Launer, Lenore
Gudnason, Vilmundur
author_facet Gudmundsson, Larus S
Scher, Ann I
Aspelund, Thor
Eliasson, Jon H
Johannsson, Magnus
Thorgeirsson, Gudmundur
Launer, Lenore
Gudnason, Vilmundur
author_sort Gudmundsson, Larus S
title Migraine with aura and risk of cardiovascular and all cause mortality in men and women: prospective cohort study
title_short Migraine with aura and risk of cardiovascular and all cause mortality in men and women: prospective cohort study
title_full Migraine with aura and risk of cardiovascular and all cause mortality in men and women: prospective cohort study
title_fullStr Migraine with aura and risk of cardiovascular and all cause mortality in men and women: prospective cohort study
title_full_unstemmed Migraine with aura and risk of cardiovascular and all cause mortality in men and women: prospective cohort study
title_sort migraine with aura and risk of cardiovascular and all cause mortality in men and women: prospective cohort study
publisher British Medical Association
publishDate 2010
url http://hdl.handle.net/2336/111153
https://doi.org/10.1136/bmj.c3966
genre Iceland
genre_facet Iceland
op_relation http://dx.doi.org/10.1136/bmj.c3966
BMJ. 2010, 341(7771):493
1468-5833
20736269
doi:10.1136/bmj.c3966
http://hdl.handle.net/2336/111153
BMJ (Clinical research ed.)
op_doi https://doi.org/10.1136/bmj.c3966
container_title BMJ
container_volume 341
container_issue aug24 1
container_start_page c3966
op_container_end_page c3966
_version_ 1766039206718603264